Westbrook-based Idexx Laboratories Inc. reported profits of 142.2 million for the third quarter, up 9 percent from the same period last year.
In its quarterly results released Friday, the veterinary biotech firm said revenue for the quarter was $269.6 million.
Earnings per diluted share rose 13 percent to 59 cents, up from 52 cents in the same period in 2009.
The firm’s third quarter 2009 revenue was $259.1 million. Profits in that period were $130.5 million.
During the third quarter, the company launched its latest blood analyzer, ProCyte Dx, and reported nearly 10 percent growth in the placement of chemistry analysis products in veterinary practices.
Year-to-date revenues were $819.6 million, up from $761.3 million for the nine months that ended Sept. 30, 2009.
The company expects 2010 revenue to be $1.1 billion and 2011 revenue between $1.18 billion and $1.2 billion.
Send questions/comments to the editors.
Success. Please wait for the page to reload. If the page does not reload within 5 seconds, please refresh the page.
Enter your email and password to access comments.
Hi, to comment on stories you must . This profile is in addition to your subscription and website login.
Already have a commenting profile? .
Invalid username/password.
Please check your email to confirm and complete your registration.
Only subscribers are eligible to post comments. Please subscribe or login first for digital access. Here’s why.
Use the form below to reset your password. When you've submitted your account email, we will send an email with a reset code.